{"id":432872,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2016-08-09] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:04:34.603000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-13.html?wbdisable=true","snippet":"Notice: Prescription Drug List (PDL): Multiple additions August 9, 2016 Our file number: 16-108811-710 The purpose of this Notice of Amendment is to notify the additions of Alirocumab, Blinatumomab, Brivaracetam, Carfilzomib, Cobimetinib, Elbasvir, Finafloxacin, Grazoprevir,…","rawSnapshotUrl":"/api/snapshots/raw/432872","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090434/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-13.html?wbdisable=true#ha_snapshot=432872","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}